Gefarnate stimulates mucin-like glycoprotein secretion in conjunctival tissue and ameliorates corneal epithelial damage in animal dry-eye models

Dota A., Takaoka-Shichijo Y., Nakamura M.

2013
Clinical Ophthalmology

View publication

Therapeutic Area

Front of the eye (FOTE)
Technology

Pharmacology
Categories

Preclinical development

Affiliations

Ophthalmic Research and Development Center, Santen Pharmaceutical Co, Ltd, 8916-16 Ikoma-shi, Nara, Japan

Related Publications

Characterization of monocarboxylate uptake and immunohistochemical demonstration of monocarboxylate transporters in cultured rabbit corneal epithelial cells

Kawazu K., Fujii S., Yamada K., Shinomiya K., Katsuta O., Horibe Y.

Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model

Liang H., Baudouin C., Daull P., Garrigue J.-S., Brignole-Baudouin F.

Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases

Kato M., Hagiwara Y., Oda T., Imamura-Takai M., Aono H., Nakamura M.

View all Front of the eye (FOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022